{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:06:02Z","timestamp":1779955562596,"version":"3.53.1"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Multiple sclerosis (MS) has traditionally been diagnosed after the onset of clinical symptoms, supported by characteristic radiological findings. However, mounting evidence suggests that MS-related biological processes may precede the first overt neurological manifestations by several years. The disease appears to unfold along a biological continuum that includes genetic susceptibility, environmental exposures, and possible early manifestations characterized by subtle, nonspecific symptoms that precede detectable abnormalities such as MRI lesions or early biomarker changes. This review summarizes current knowledge about the temporal evolution of MS, from early risk factors through the radiologically isolated syndrome (RIS) and clinically isolated syndrome (CIS), to the onset of clinically definite MS. We discuss emerging biomarkers, advances in neuroimaging, and evolving insights into early immunopathological mechanisms. Conceptualizing MS as a continuum may facilitate improved risk stratification and the development of targeted monitoring strategies in individuals at higher risk. Nevertheless, this model remains limited by the absence of biomarkers with sufficient specificity to reliably characterize preclinical or prodromal biological disease activity, and of validated tools to translate such findings into clinical practice.<\/jats:p>","DOI":"10.3389\/fneur.2026.1812340","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:57:51Z","timestamp":1779955071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Ana Bel\u00e9n","family":"Caminero","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Unit, Department of Neurology, Complejo Asistencial de \u00c1vila","place":["\u00c1vila, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00ednez Gin\u00e9s","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Unit, Department of Neurology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"G\u00f3mez Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital San Pedro de Alc\u00e1ntara","place":["C\u00e1ceres, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Garc\u00eda Casta\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Fuenlabrada","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.17879\/freeneuropathology-2025-6762","article-title":"Multiple sclerosis: 2024 update","volume":"6","author":"Klotz","year":"2025","journal-title":"Free Neuropathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e1003926","DOI":"10.1371\/journal.pgen.1003926","article-title":"Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects","volume":"9","author":"Patsopoulos","year":"2013","journal-title":"PLoS Genet"},{"key":"ref4","first-page":"214","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume-title":"Nature","author":"Sawcer","year":"2011"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"363ra149","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/gene.2014.36","article-title":"The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation","volume":"15","author":"Laaksonen","year":"2014","journal-title":"Genes Immun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"103834","DOI":"10.1016\/j.msard.2022.103834","article-title":"Genetic biomarkers in multiple sclerosis: an umbrella review of meta-analyses of observational studies","volume":"63","author":"Tempest","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1437778","DOI":"10.3389\/fneur.2024.1437778","article-title":"Combining gene expression microarrays and mendelian randomization: exploring key immune-related genes in multiple sclerosis","volume":"15","author":"Ding","year":"2024","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2018.00622","article-title":"B cell modulation strategies in autoimmune diseases: new concepts","volume":"9","author":"Musette","year":"2018","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1177\/1352458514564492","article-title":"Twin studies in multiple sclerosis: a meta-estimation of heritability and environmentality","volume":"21","author":"Fagnani","year":"2015","journal-title":"Mult Scler"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/13524585231185258","article-title":"The familial risk and heritability of multiple sclerosis and its onset phenotypes: a case-control study","volume":"29","author":"Boles","year":"2023","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.msard.2017.12.015","article-title":"Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis","volume":"20","author":"Harirchian","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12883-021-02267-9","article-title":"The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis","volume":"21","author":"Ehtesham","year":"2021","journal-title":"BMC Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1352458519872664","article-title":"Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies","volume":"26","author":"Belbasis","year":"2020","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"jnnp-2023-331868-32","DOI":"10.1136\/jnnp-2023-331868","article-title":"Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage","volume":"95","author":"Jons","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","article-title":"Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses","volume":"14","author":"Belbasis","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/ije\/dyu195","article-title":"Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk","volume":"43","author":"Hedstrom","year":"2014","journal-title":"Int J Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awq371","article-title":"Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis","volume":"134","author":"Hedstrom","year":"2011","journal-title":"Brain"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"840158","DOI":"10.3389\/fimmu.2022.840158","article-title":"Smoking attributable risk in multiple sclerosis","volume":"13","author":"Manouchehrinia","year":"2022","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/brain\/awt139","article-title":"Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study","volume":"136","author":"Manouchehrinia","year":"2013","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e1001866","DOI":"10.1371\/journal.pmed.1001866","article-title":"Vitamin D and risk of multiple sclerosis: a mendelian randomization study","volume":"12","author":"Mokry","year":"2015","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1212\/NXG.0000000000000097","article-title":"Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk","volume":"2","author":"Rhead","year":"2016","journal-title":"Neurol Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00415-020-10119-8","article-title":"An atlas on risk factors for multiple sclerosis: a mendelian randomization study","volume":"268","author":"Yuan","year":"2021","journal-title":"J Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1111\/ejn.16088","article-title":"A systematic review of mendelian randomization studies on multiple sclerosis","volume":"58","author":"Fazia","year":"2023","journal-title":"Eur J Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e1000369","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"Ramagopalan","year":"2009","journal-title":"PLoS Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00415-019-09677-3","article-title":"Low sun exposure increases multiple sclerosis risk both directly and indirectly","volume":"267","author":"Hedstrom","year":"2020","journal-title":"J Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1159\/000540921","article-title":"Low sun exposure is associated with both progressive-onset and relapse-onset multiple sclerosis risk: a case-control study","volume":"59","author":"van der Mei","year":"2025","journal-title":"Neuroepidemiology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/aje\/kww120","article-title":"Causal effect of genetic variants associated with body mass index on multiple sclerosis susceptibility","volume":"185","author":"Gianfrancesco","year":"2017","journal-title":"Am J Epidemiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1177\/13524585211001781","article-title":"Childhood obesity and multiple sclerosis: a mendelian randomization study","volume":"27","author":"Harroud","year":"2021","journal-title":"Mult Scler"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e1002053","DOI":"10.1371\/journal.pmed.1002053","article-title":"Obesity and multiple sclerosis: a mendelian randomization study","volume":"13","author":"Mokry","year":"2016","journal-title":"PLoS Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.3390\/jcm10122689","article-title":"Obesity and multiple sclerosis-a multifaceted association","volume":"10","author":"Schreiner","year":"2021","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1352458515603798","article-title":"Body mass index during adolescence, rather than childhood, is critical in determining MS risk","volume":"22","author":"Hedstrom","year":"2016","journal-title":"Mult Scler"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/WNL.0000000000000203","article-title":"Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis","volume":"82","author":"Hedstrom","year":"2014","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI88876","article-title":"Role of innate and adaptive immunity in obesity-associated metabolic disease","volume":"127","author":"McLaughlin","year":"2017","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1684\/ecn.2021.0474","article-title":"Metabolic link between obesity and autoimmune diseases","volume":"32","author":"Karczewski","year":"2021","journal-title":"Eur Cytokine Netw"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cellimm.2017.03.001","article-title":"Role of immune cells in obesity induced low grade inflammation and insulin resistance","volume":"315","author":"Asghar","year":"2017","journal-title":"Cell Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1177\/1352458515604380","article-title":"Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune study","volume":"22","author":"Hoare","year":"2016","journal-title":"Mult Scler"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1177\/1352458519872652","article-title":"Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility","volume":"26","author":"Langer-Gould","year":"2020","journal-title":"Mult Scler"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1410745","DOI":"10.3389\/fnut.2024.1410745","article-title":"Causal effects of dietary composition on multiple sclerosis risk and severity: a mendelian randomization study","volume":"11","author":"Nan","year":"2024","journal-title":"Front Nutr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1073\/pnas.0500398102","article-title":"Epigenetic differences arise during the lifetime of monozygotic twins","volume":"102","author":"Fraga","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nature08990","article-title":"Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis","volume":"464","author":"Baranzini","year":"2010","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e23555","DOI":"10.1002\/jbt.23555","article-title":"Relation between microRNA-155 and inflammatory mediators in multiple sclerosis","volume":"38","author":"Elsayed","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","article-title":"Contribution of MicroRNAs to autoimmune diseases","volume":"73","author":"Garo","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1177\/1352458513516529","article-title":"Methylation differences at the HLA-DRB1 locus in CD4+ T-cells are associated with multiple sclerosis","volume":"20","author":"Graves","year":"2014","journal-title":"Mult Scler"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47","volume":"132","author":"Junker","year":"2009","journal-title":"Brain"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13148-017-0371-1","article-title":"Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1","volume":"9","author":"Maltby","year":"2017","journal-title":"Clin Epigenetics"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.4049\/jimmunol.1003952","article-title":"Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis","volume":"187","author":"Murugaiyan","year":"2011","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/1352458519879303","article-title":"microRNA and exosome profiling in multiple sclerosis","volume":"26","author":"Mycko","year":"2020","journal-title":"Mult Scler"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"O'Connell","year":"2010","journal-title":"Immunity"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaneurol.2016.5056","article-title":"Assessment of early evidence of multiple sclerosis in a prospective study of asymptomatic high-risk family members","volume":"74","author":"Xia","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pediatrneurol.2024.09.005","article-title":"The multiple sclerosis prodrome in a retrospective Pediatric cohort","volume":"161","author":"Barter","year":"2024","journal-title":"Pediatr Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e2026","DOI":"10.1212\/WNL.0000000000207843","article-title":"Psychiatric comorbidity during the prodromal period in patients with multiple sclerosis","volume":"101","author":"Chertcoff","year":"2023","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ana.24769","article-title":"Preclinical disease activity in multiple sclerosis: a prospective study of cognitive performance prior to first symptom","volume":"80","author":"Cortese","year":"2016","journal-title":"Ann Neurol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ana.25247","article-title":"Prodromal symptoms of multiple sclerosis in primary care","volume":"83","author":"Disanto","year":"2018","journal-title":"Ann Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s10194-024-01941-w","article-title":"Migraine in the multiple sclerosis prodrome: a prospective nationwide cohort study in pregnant women","volume":"25","author":"Eid","year":"2024","journal-title":"J Headache Pain"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"103154","DOI":"10.1016\/j.msard.2021.103154","article-title":"Defining the prodromal phase of multiple sclerosis based on healthcare access in a Portuguese population - ProdMS study","volume":"55","author":"Jorge","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5603\/PJNNS.a2023.0035","article-title":"Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis","volume":"57","author":"Kania","year":"2023","journal-title":"Neurol Neurochir Pol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"Radiologically isolated syndrome: 10-year risk estimate of a clinical event","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/jnnp-2024-335279","article-title":"Prodromal phase of multiple sclerosis: evidence from sickness absence patterns before disease onset - a matched cohort study","volume":"96","author":"Manouchehrinia","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e90509","DOI":"10.1371\/journal.pone.0090509","article-title":"Radiologically isolated syndrome: 5-year risk for an initial clinical event","volume":"9","author":"Okuda","year":"2014","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/ene.13925","article-title":"Prodrome in relapsing-remitting and primary progressive multiple sclerosis","volume":"26","author":"Wijnands","year":"2019","journal-title":"Eur J Neurol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1352458520908163","article-title":"Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome","volume":"27","author":"Yusuf","year":"2021","journal-title":"Mult Scler"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000505331","article-title":"Interrogation of the multiple sclerosis prodrome using high-dimensional health data","volume":"54","author":"Zhao","year":"2020","journal-title":"Neuroepidemiology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/acn3.52267","article-title":"Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex","volume":"12","author":"Tremlett","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"106595","DOI":"10.1016\/j.msard.2025.106595","article-title":"Heterogeneity in health care pathways preceding the classical recognition of adult-onset multiple sclerosis: a multichannel state sequence analysis","volume":"102","author":"Yusuf","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"106560","DOI":"10.1016\/j.msard.2025.106560","article-title":"Informative patterns of health care utilization preceding the recognition of adult-onset multiple sclerosis: a population-based study","volume":"101","author":"Yusuf","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/14737175.2020.1746645","article-title":"A systematic review of morbidities suggestive of the multiple sclerosis prodrome","volume":"20","author":"Yusuf","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1352458515588973","article-title":"Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis","volume":"22","author":"Hoang","year":"2016","journal-title":"Mult Scler"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1017\/S2045796017000579","article-title":"Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease","volume":"28","author":"Marrie","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/1352458518783662","article-title":"Five years before multiple sclerosis onset: phenotyping the prodrome","volume":"25","author":"Wijnands","year":"2019","journal-title":"Mult Scler"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.msard.2020.102420","article-title":"Infections in patients with multiple sclerosis: a national cohort study in Sweden","volume":"45","author":"Castelo-Branco","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00415-019-09238-8","article-title":"Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries","volume":"266","author":"Persson","year":"2019","journal-title":"J Neurol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/1352458514554054","article-title":"School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis","volume":"21","author":"Sinay","year":"2015","journal-title":"Mult Scler"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.msard.2018.08.007","article-title":"Mining healthcare data for markers of the multiple sclerosis prodrome","volume":"25","author":"Hogg","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study","volume":"16","author":"Langer-Gould","year":"2010","journal-title":"Mult Scler"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","volume":"77","author":"Bjornevik","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/s41467-025-61751-9","article-title":"Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1(381-452)-specific antibody titers","volume":"16","author":"Vietzen","year":"2025","journal-title":"Nat Commun"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/s1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Frenay","year":"2023","journal-title":"Brain"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/13524585241245306","article-title":"Radiologically isolated syndrome in the spectrum of multiple sclerosis","volume":"30","author":"Okuda","year":"2024","journal-title":"Mult Scler"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/13524585241291471","article-title":"Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome","volume":"31","author":"Lebrun-Frenay","year":"2025","journal-title":"Mult Scler"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/13524585241312758","article-title":"Before the before: is there a prodrome in patients with radiologically isolated syndrome?","volume":"31","author":"Louapre","year":"2025","journal-title":"Mult Scler"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e200156","DOI":"10.1212\/NXI.0000000000200156","article-title":"Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes","volume":"10","author":"Levraut","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awy021","article-title":"Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome","volume":"141","author":"Matute-Blanch","year":"2018","journal-title":"Brain"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"e2497","DOI":"10.1212\/WNL.0000000000207981","article-title":"Association between diseases and symptoms diagnosed in primary care and the subsequent specific risk of multiple sclerosis","volume":"101","author":"Guinebretiere","year":"2023","journal-title":"Neurology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/jnnp.2008.166421","article-title":"Prior suggestive symptoms in one-third of patients consulting for a \"first\" demyelinating event","volume":"82","author":"Gout","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","article-title":"Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome","volume":"93","author":"Okuda","year":"2023","journal-title":"Ann Neurol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2023.2815","article-title":"Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial","volume":"80","author":"Lebrun-Frenay","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.jocn.2014.02.026","article-title":"Clinically isolated syndromes and the relationship to multiple sclerosis","volume":"21","author":"Brownlee","year":"2014","journal-title":"J Clin Neurosci"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/13524585231225848","article-title":"Optic nerve topography in multiple sclerosis diagnostic criteria: existing knowledge and future directions","volume":"30","author":"Vidal-Jordana","year":"2024","journal-title":"Mult Scler J"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/revneuro-2020-0145","article-title":"Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis","volume":"32","author":"Momtazmanesh","year":"2021","journal-title":"Rev Neurosci"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1162340","DOI":"10.3389\/fimmu.2023.1162340","article-title":"Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review","volume":"14","author":"Temmerman","year":"2023","journal-title":"Front Immunol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.nrleng.2021.01.010","article-title":"Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis","volume":"38","author":"L\u00f3pez-G\u00f3mez","year":"2023","journal-title":"Neurologia (Engl Ed)"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00415-022-11488-y","article-title":"Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective","volume":"270","author":"Filippi","year":"2023","journal-title":"J Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fneur.2019.00188","article-title":"Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front Neurol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"792192","DOI":"10.5402\/2012\/792192","article-title":"Predictors of conversion to multiple sclerosis in patients with clinical isolated syndrome using the 2010 revised McDonald criteria","volume":"2012","author":"Alroughani","year":"2012","journal-title":"ISRN Neurol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00415-013-6838-x","article-title":"Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study","volume":"260","author":"D'Alessandro","year":"2013","journal-title":"J Neurol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1038\/s41598-018-29206-y","article-title":"Natural course of clinically isolated syndrome: a longitudinal analysis using a Markov model","volume":"8","author":"Hou","year":"2018","journal-title":"Sci Rep"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1177\/1120672120983179","article-title":"Systematic review and meta-analysis of the development of multiple sclerosis in clinically isolated syndrome","volume":"31","author":"Al-Namaeh","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"17562864241284372","DOI":"10.1177\/17562864241284372","article-title":"Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management","volume":"17","author":"Oreja-Guevara","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42466-024-00310-x","article-title":"Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study","volume":"6","author":"Bayas","year":"2024","journal-title":"Neurol Res Pract"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e880","DOI":"10.1212\/NXI.0000000000000880","article-title":"CSF neurofilament light chain testing as an aid to determine treatment strategies in MS","volume":"7","author":"Reyes","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40263-019-00647-x","article-title":"Drug treatment of clinically isolated syndrome","volume":"33","author":"F\u00f6rster","year":"2019","journal-title":"CNS Drugs"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00415-018-8752-8","article-title":"Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis","volume":"265","author":"Armoiry","year":"2018","journal-title":"J Neurol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"101023","DOI":"10.1016\/j.lanepe.2024.101023","article-title":"Emerging MRI and biofluid biomarkers in the diagnosis and prognosis of multiple sclerosis","volume":"44","author":"Anderhalten","year":"2024","journal-title":"Lancet Reg Health Eur."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.lanepe.2025.101302","article-title":"The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study","volume":"53","author":"Tur","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e200370","DOI":"10.1212\/nxi.0000000000200370","article-title":"Contribution of blood biomarkers to multiple sclerosis diagnosis","volume":"12","author":"Comabella","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","article-title":"Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis","volume":"81","author":"Cross","year":"2024","journal-title":"JAMA Neurol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"101009","DOI":"10.1016\/j.lanepe.2024.101009","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications","volume":"44","author":"Di Filippo","year":"2024","journal-title":"The Lancet Regional Health - Europe"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00415-025-12917-4","article-title":"Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion","volume":"272","author":"Filippi","year":"2025","journal-title":"J Neurol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"e200253","DOI":"10.1212\/nxi.0000000000200253","article-title":"Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis","volume":"11","author":"Borrelli","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"17562864241306684","DOI":"10.1177\/17562864241306684","article-title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","volume":"17","author":"Dal-Bianco","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neurad.2023.11.007","article-title":"MRI features and disability in multiple sclerosis: a systematic review and meta-analysis","volume":"51","author":"Nabizadeh","year":"2024","journal-title":"J Neuroradiol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"e0312421","DOI":"10.1371\/journal.pone.0312421","article-title":"Neuroimaging markers and disability scales in multiple sclerosis: a systematic review and meta-analysis","volume":"19","author":"Mirmosayyeb","year":"2024","journal-title":"PLoS One"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"17562864241303681","DOI":"10.1177\/17562864241303681","article-title":"A systematic literature review of the association between global brain atrophy and the expanded disability status scale score in people with multiple sclerosis","volume":"18","author":"Zivadinov","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"e221512","DOI":"10.1148\/radiol.221512","article-title":"Emerging perspectives on MRI application in multiple sclerosis: moving from pathophysiology to clinical practice","volume":"307","author":"Rocca","year":"2023","journal-title":"Radiology"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"666868","DOI":"10.3389\/fneur.2021.666868","article-title":"Clinical and paraclinical biomarkers and the hitches to assess conversion to secondary progressive multiple sclerosis: a systematic review","volume":"12","author":"Krajnc","year":"2021","journal-title":"Front Neurol"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/acn3.52165","article-title":"Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta-analysis","volume":"11","author":"El Ayoubi","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"e200416","DOI":"10.1212\/nxi.0000000000200416","article-title":"Retinal optical coherence tomography longitudinal measures as prognostic biomarkers in multiple sclerosis: systematic review and Meta-analysis","volume":"12","author":"El Ayoubi","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00415-022-11449-5","article-title":"Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis","volume":"270","author":"Mirmosayyeb","year":"2023","journal-title":"J Neurol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12974-023-02763-4","article-title":"Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis","volume":"20","author":"Mohammadi","year":"2023","journal-title":"J Neuroinflammation"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1111\/ene.14416","article-title":"Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis","volume":"27","author":"Aly","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"10.3390\/brainsci11111444","DOI":"10.3390\/brainsci11111444","article-title":"Cerebrospinal fluid IgM and oligoclonal IgG bands in multiple sclerosis: a meta-analysis of prevalence and prognosis","volume":"11","author":"Fonderico","year":"2021","journal-title":"Brain Sci"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1212\/nxi.0000000000001047","article-title":"Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome","volume":"8","author":"Monreal","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1007\/s00415-023-11817-9","article-title":"Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis","volume":"270","author":"Rosenstein","year":"2023","journal-title":"J Neurol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1571605","DOI":"10.3389\/fneur.2025.1571605","article-title":"Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice","volume":"16","author":"Centonze","year":"2025","journal-title":"Front Neurol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00415-025-13093-1","article-title":"The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review","volume":"272","author":"Freedman","year":"2025","journal-title":"J Neurol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"e0274565","DOI":"10.1371\/journal.pone.0274565","article-title":"Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis","volume":"17","author":"Ning","year":"2022","journal-title":"PLoS One"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"e2147588","DOI":"10.1001\/jamanetworkopen.2021.47588","article-title":"Serum neurofilament light and multiple sclerosis progression independent of acute inflammation","volume":"5","author":"Gafson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1007\/s00415-020-09917-x","article-title":"Neurofilaments in progressive multiple sclerosis: a systematic review","volume":"268","author":"Williams","year":"2021","journal-title":"J Neurol"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1093\/brain\/awae260","article-title":"Serum biomarkers at disease onset for personalized therapy in multiple sclerosis","volume":"147","author":"Monreal","year":"2024","journal-title":"Brain"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/acn3.52187","article-title":"Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis","volume":"11","author":"Madill","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"105410","DOI":"10.1016\/j.msard.2023.105410","article-title":"Evaluating the clinical utility of Epstein-Barr virus antibodies as biomarkers in multiple sclerosis: a systematic review","volume":"84","author":"Bose","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1177\/1352458520907901","article-title":"Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors","volume":"26","author":"Jacobs","year":"2020","journal-title":"Mult Scler"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"106031","DOI":"10.1016\/j.micpath.2023.106031","article-title":"Association between human herpesviruses and multiple sclerosis: a systematic review and meta-analysis","volume":"177","author":"Khalesi","year":"2023","journal-title":"Microb Pathog"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/brain\/awac092","article-title":"Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans","volume":"146","author":"Shams","year":"2023","journal-title":"Brain"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"e200062","DOI":"10.1212\/nxi.0000000000200062","article-title":"Association of vitamin D polygenic risk scores and disease outcome in people with multiple sclerosis","volume":"10","author":"Vasileiou","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"e0233575","DOI":"10.1371\/journal.pone.0233575","article-title":"Systematic review of prediction models in relapsing remitting multiple sclerosis","volume":"15","author":"Brown","year":"2020","journal-title":"PLoS One"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"Cd013606","DOI":"10.1002\/14651858.CD013606.pub2","article-title":"Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis","volume":"9","author":"Reeve","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"e209663","DOI":"10.1212\/wnl.0000000000209663","article-title":"Association of Polygenic Risk Score with Lifetime Risk of developing multiple sclerosis in a population-based birth-year cohort","volume":"103","author":"Loonstra","year":"2024","journal-title":"Neurology"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41467-024-44917-9","article-title":"Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis","volume":"15","author":"Loginovic","year":"2024","journal-title":"Nat Commun"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"866092","DOI":"10.3389\/fimmu.2022.866092","article-title":"Biological markers in early multiple sclerosis: the paved way for radiologically isolated syndrome","volume":"13","author":"Rival","year":"2022","journal-title":"Front Immunol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"10.3390\/ijms25042255","DOI":"10.3390\/ijms25042255","article-title":"Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways","volume":"25","author":"Cipriano","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae209","article-title":"Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing","volume":"6","author":"Tan","year":"2024","journal-title":"Brain Commun"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"e200133","DOI":"10.1212\/nxi.0000000000200133","article-title":"TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis","volume":"10","author":"Polvinen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"106546","DOI":"10.1016\/j.msard.2025.106546","article-title":"TSPO PET in multiple sclerosis: emerging insights into pathophysiology, prognosis, and treatment monitoring","volume":"100","author":"Guido","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/13524585251340812","article-title":"The path to prevention of multiple sclerosis: considerations for Epstein-Barr virus vaccine-based prevention studies","volume":"31","author":"Zane","year":"2025","journal-title":"Mult Scler"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/jnnp-2024-334062","article-title":"Vitamin D affects the risk of disease activity in multiple sclerosis","volume":"96","author":"Giordano","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/wno.0000000000002149","article-title":"The study of remyelinating therapies in multiple sclerosis: visual outcomes as a window into repair","volume":"44","author":"Zuroff","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/14737175.2025.2510405","article-title":"Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms","volume":"25","author":"Coclitu","year":"2025","journal-title":"Expert Rev Neurother"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/09638288.2022.2046187","article-title":"Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies","volume":"45","author":"Topcu","year":"2023","journal-title":"Disabil Rehabil"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/medethics-2011-100063","article-title":"Care ethics for guiding the process of multiple sclerosis diagnosis","volume":"40","author":"Krahn","year":"2014","journal-title":"J Med Ethics"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"106143","DOI":"10.1016\/j.msard.2024.106143","article-title":"Preferences and attitudes regarding early intervention in multiple sclerosis: a systematic literature review","volume":"92","author":"Martin","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s40120-024-00654-1","article-title":"Patient and physician perspectives of treatment burden in multiple sclerosis","volume":"13","author":"Singer","year":"2024","journal-title":"Neurol Ther"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"106756","DOI":"10.1016\/j.msard.2025.106756","article-title":"Diagnostic evolution in multiple sclerosis: a narrative review of the McDonald criteria from 2001 to 2024","volume":"104","author":"Agrawal","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1177\/13524585251351860","article-title":"2024 revision of the McDonald diagnostic criteria for MS: substantial and substantive changes","volume":"31","author":"Cohen","year":"2025","journal-title":"Mult Scler"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10072-024-07930-w","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis: a systematic review and meta-analysis","volume":"46","author":"Liampas","year":"2025","journal-title":"Neurol Sci"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"102816","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and Meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1812340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:57:55Z","timestamp":1779955075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1812340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":173,"alternative-id":["10.3389\/fneur.2026.1812340"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1812340","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1812340"}}